Clinical and demographic characteristics of patients (pts) treated with vemurafenib in real-world setting

被引：0
|
作者：
Sadetsky, N. [1 ]
Corvino, F. [2 ]
Surinach, A. [2 ]
Goodman, G. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Genesis Res LLC, Hoboken, NJ USA
来源：
MELANOMA RESEARCH | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P062
引用
收藏
页码：E42 / E42
页数：1
相关论文
共 50 条
  • [31] Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab
    Ke, Xuehua
    Kavati, Abhishek
    Wertz, Debra
    Huang, Qing
    Wang, Liya
    Willey, Vincent J.
    Stephenson, Judith J.
    Ortiz, Benjamin
    Panettieri, Reynold A., Jr.
    Corren, Jonathan
    CLINICAL THERAPEUTICS, 2018, 40 (07) : 1140 - 1158
  • [32] First clinical experiences with inclisiran in a real-world setting
    Mulder, Janneke W. C. M.
    Galema-Boers, Annette M. H.
    van Lennep, Jeanine E. Roeters
    JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (06) : 818 - 827
  • [33] Efficacy and tolerability of teriflunomide in a real-world clinical setting
    Duquette, P.
    Roger, E.
    Nadeau, N.
    Hum, S.
    Bigras, C.
    Despault, P.
    Lapierre, Y.
    Grand'Maison, F.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 245 - 246
  • [34] Initial experience with teriflunomide in a real-world clinical setting
    Duquette, P.
    Roger, E.
    Nadeau, N.
    Hum, S.
    Bigras, C.
    Despault, P.
    Lapierre, Y.
    Grand'Maison, F.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 243 - 243
  • [35] Real-world dosing, management, and clinical outcomes of patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC) treated with liposomal irinotecan.
    Abushahin, Laith, I
    Cockrum, Paul
    Surinach, Andy
    Belanger, Bruce
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Baseline characteristics of patients enrolled in LEMQoL, a study assessing health-related quality of life in RRMS patients treated with alemtuzumab in a real-world clinical setting
    Van Wijmeersch, B.
    Patti, F.
    Hobart, J.
    Kizlaitiene, R.
    Vanderdonckt, P.
    Shor, S.
    Andreasen, A. K.
    Uitdehaag, B. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 866 - 866
  • [37] Impact of Natalizumab on Economic and Clinical Outcomes in MS Patients in the Real-World Setting
    Cai, Qian
    Tan, Hiangkiat
    Agarwal, Sonalee
    Kamat, Siddhesh
    NEUROLOGY, 2010, 74 (09) : A65 - A65
  • [38] Liraglutide Effectiveness in Real-World Clinical Setting in Croatia
    Berkovic, Maja Cigrovski
    Bilic-Curcic, Ines
    Gradiser, Marina
    Mahecic, Davorka Herman
    Grgurevic, Miaden
    DIABETES, 2017, 66 : A298 - A298
  • [39] Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting
    Zanichelli, Andrea
    Longhurst, Hilary J.
    Maurer, Marcus
    Bouillet, Laurence
    Aberer, Werner
    Fabien, Vincent
    Andresen, Irmgard
    Caballero, Teresa
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (04) : 394 - 398
  • [40] Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting
    Pedersen, Sidsel
    Larsen, Kirstine Ostenfeld
    Christensen, Alex Horby
    Svane, Inge Marie
    Zerahn, Bo
    Ellebaek, Eva
    ACTA ONCOLOGICA, 2022, 61 (01) : 45 - 51
12345